[ORGANIZATION]
Amphenol
Featured in 1 tracked story · first seen
Situations
Silence Therapeutics financial and clinical developments
2 clusters · 3 sources · last updated
Latest: Silence Therapeutics stock rises 111 percent on successful clinical trial results
Silence Therapeutics, a biotechnology company specializing in RNA interference (RNAi) and siRNA therapies, has experienced significant financial and clinical developments. In August 2026, the company upsized a public of